Navigation Links
Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
Date:10/31/2007

abetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione. BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney.

When BYETTA is used with a medicine that contains a sulfonylurea, low blood sugar (hypoglycemia) is a possible side effect. To reduce this possibility, the dose of sulfonylurea medicine may need to be reduced while using BYETTA. Other common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea is most common when first starting BYETTA, but decreases over time in most patients.

If patients experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, they should talk to their healthcare provider because these symptoms could be signs of serious medical conditions. BYETTA may reduce appetite, the amount of food eaten, and body weight. No changes in dose are needed for these side effects. These are not all the side effects with BYETTA. A health care provider should be consulted about any side effect that is bothersome or does not go away.

For complete safety profile and other important prescribing considerations, visit http://www.BYETTA.com.

About Amylin, Lilly, and Alkermes

Amylin, Lilly, and Alkermes are working together to develop exenatide long-acting release injection, a subcutaneous injection of exenatide for the treatment of type 2 diabetes based on Alkermes' proprietary injectable long- acting release technology. Once-weekly exenatide has not been approved by the FDA for marketing in the United States or by regulatory agencies elsewhere in the world.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives throu
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Diabetes Drug, Exenatide, Good For Blood Sugar Levels and Weight Loss
2. Osaka Medical Center study showed 70% of smokers couldn’t qui
3. Women Taking Oestrogen Therapy Showed Reduced Coronary Artery Calcification
4. Link Between Vietnam Service And Prostate Cancer Is Statistically Insignificant
5. Biomarkers Predicting Mortality Found Using Statistical Technique
6. Manmohan Calls for Statistical Reforms in Healthcare and Education
7. Treatment For Sleep Apnea Found To Lower Blood Glucose Levels
8. More soy benefits on blood glucose levels, and cholesterol
9. Lower risk of cardiovascular disease from tight glucose control
10. Glucose may support in Cardiac Arrest
11. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... ENT and Allergy Associates, LLP (ENTA) does not ... , New York/New Jersey’s premier ear, nose, throat, ... offering superior healthcare to children and adults in hundreds ... York area-only considers adding to its current footprint when ... the right communities to serve, the right locations from ...
(Date:6/18/2013)... 2013 Palo Alto has taken yet another ... cities with its recent major long-term solar power commitment. ... solar electric power purchase agreements , which together will result ... solar photovoltaic electric power per year, which is the equivalent ... That’s enough power to supply all 65,000+ Palo Alto residents---and ...
(Date:6/18/2013)... Biomet hip lawsuit claims involving ... a multidistrict litigation in U.S. District Court, Northern District ... court records, the litigation’s most recent status conference was ... also convened a motions hearing and a tutorial on ... hip replacement litigation. The proceeding’s next Status Conference ...
(Date:6/18/2013)... Sun Buick GMC, Moosic, is sponsoring the hole-in-one contest at ... on Thursday, June 20, at Irem Country Club, Dallas, Pennsylvania. ... Verano and will go to the lucky golfer at the ... , The MFHS golf tournament is open to all interested ... crew team for 18 holes. The fee is $125 per ...
(Date:6/18/2013)... June 18, 2013 Seven-year-old Riley Salz ... from autism. He receives 40 hours a week of ... shadowing) from the Center for Autism and Related Disorders ... August, 2008, and has experienced remarkable progress, including learning ... his environment. Riley’s personal journey through autism is now ...
Breaking Medicine News(10 mins):Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3
... Coordinating and timing,activities is a top challenge that ... landmark clinical trials. Best-in-class,companies understand that successfully communicating ... findings are available. Successful,communication depends on early actions ... of breakthrough molecules in development -- Early ...
... UK and PHILADELPHIA, US June 17 ,Shire Limited ... today announced the publication of data from a,randomized, ... colitis (UC) drug Lialda(TM) (mesalamine). The primary endpoints,of ... tolerability of Lialda in,mild-to-moderate UC patients over 12 ...
... on octopuses has shed new light on how our ... of the Department of Neurobiology at the Alexander Silberman ... Jerusalem., Why octopuses?, Octopuses and other related creatures, known ... invertebrates because they have relatively large brains and they ...
... second it takes an ambulance to get to its ... driving faster, can ambulances get emergency services to people ... a classic operations research question that three Cornell researchers ... Foundation grant of almost $300,000 is allowing associate professor ...
... Europe,s position as a major player in genome ... Foundation,s three-year EUROCORES programme EuroDYNA. As it draws ... Chromatin Function) is leaving behind a healthy European ... the structure of the cellular nucleus and mechanisms ...
... tumor hypoglycemia (NICTH) is a rare association between ... than the pancreatic islets. It was initially associated ... types have been described. , The pathogenesis ... of mechanisms, including excessive consumption of glucose by ...
Cached Medicine News:Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 2Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 3Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 4Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 5Health News:Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal 6Health News:Hebrew University research on octopuses sheds light on memory 2Health News:Hebrew University research on octopuses sheds light on memory 3Health News:Cornell efficiency experts seek to save precious minutes in deploying ambulances 2Health News:EuroDYNA leaves healthy genomic research ecosystem as legacy 2Health News:EuroDYNA leaves healthy genomic research ecosystem as legacy 3
(Date:6/17/2013)... 2013 Velplex, LLC announced this week that ... that connects buyers and sellers of discount dental ... Why? It,s because the business leaders ... with the dental industry. They have 50 years of ... worked to negotiate some of the best prices in ...
(Date:6/17/2013)... HOUSTON , June 17, 2013 DNAtrix ... its CEO will present clinical data on the company,s ... meeting in Quebec City, Canada ... Tufaro , DNAtrix,s CEO and a leader in the ... a clinical study entitled A PHASE I TRIAL OF ...
(Date:6/17/2013)... ST. PAUL, Minn. , June 17, 2013 ... and branding and design agency, Larsen, was awarded the Silver ... Purpose, Repositioning Prime Therapeutics." The award was presented at the ... Awards Ceremony held June 13 at the AXA ... The Silver Anvil, which has been presented ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2
Khosla Precision and Quality in Medical and Surgical Products....
Manual Table For Slit Lamp...
Khosla Precision and Quality in Medical and Surgical Products....
...
Medicine Products: